US Stocks
Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc (RCKT)


  • $







Key Stats

Today Low/High$28.8 / $30.11
52 Week Low/High$26.72 / $67.48
Market Cap$1.86B

Company Details

Rocket Pharmaceuticals, Inc. is advancing an integrated and sustainable pipeline of genetic therapies that correct the root cause of complex and rare childhood disorders. The Company's platform-agnostic approach enables it to design the best therapy for each indication, creating potentially transformative options for patients afflicted with rare genetic diseases. Rocket's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, Pyruvate Kinase Deficiency (PKD) a rare, monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia, and Infantile Malignant Osteopetrosis (IMO), a bone marrow-derived disorder. Rocket's first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon disease, a devastating, pediatric heart failure condition.
OrganisationRocket Pharmaceuticals Inc
HeadquatersNew York, New York, US
IndustryHealth Technology
CEODavid Southwell

Discover more

Frequently Asked Questions

What is Rocket Pharmaceuticals Inc (RCKT) share price today?

Can Indians buy Rocket Pharmaceuticals Inc (RCKT) shares?

How can I buy Rocket Pharmaceuticals Inc (RCKT) shares from India?

Can Fractional shares of Rocket Pharmaceuticals Inc (RCKT) be purchased?

What are the documents required to start investing in Rocket Pharmaceuticals Inc (RCKT) stocks?

We are a SEBI registered investement advisor